VergheseMathewMDFACC, FSCAI

Summary

• Dr. Mathew is Director, Interventional Cardiology at Swedish Hospital NorthShore University HealthSystem. He is also Director of WNICER, a global think tank and clinical trials collaborative which includes over 400 investigators around the world that have worked together on various trials, funded through federal and other sources. Until December, 2019 he was the Director, Division of Cardiology at Loyola University Medical Center, and held the rank of Professor of Medicine at Loyola University Chicago Stritch School of Medicine, and the William B. Knapp, MD Chair in Cardiology.
  
  Dr. Mathew has been a high volume academic interventional cardiologist for more than 2 decades. He was a consultant cardiologist at Mayo Clinic from 1997-2016, holding a number of leadership positions in the cardiac and vascular arenas, with joint appointments in the departments of medicine, cardiology, and radiology; he was recruited to Loyola University Medical Center in 2016 to lead the division of cardiology.
  
  Dr. Mathew has done extensive work in the field of interventional cardiology including complex CAD, peripheral arterial interventions, and TAVR- with both basic and translational research programs. He has been an investigator in many trials that have evaluated and led to the approval of currently utilized technologies, such as coronary stents/drug eluting stents and transcatheter aortic valve replacement (TAVR); as well as phase II-IV pharmacologic studies focused on antiplatelet and anticoagulant drugs in the context of coronary interventions. He has published extensively in the field of interventional cardiology. Dr. Mathew has a keen interest in integrated models of care, focusing on the appropriate application of advanced cardiovascular therapies to complex patient subsets. He continues to be an invited speaker at many national and international cardiovascular scientific conferences.